Just In
- 2 hrs ago Aditi Rao Hydari's 8 Tips for Glowing Skin: A Celebrity Skincare Routine Unveiled, Bonus Tips Included!
- 3 hrs ago April 2024 Health Horoscope: Know How This Month Will Affect Zodiac Signs In Terms Of Wellness
- 4 hrs ago Good Friday 2024: Wishes, Messages, Greetings, Texts, Images, Quotes, WhatsApp, And FB Status
- 11 hrs ago Aditi Rao Hydari Marries Siddharth, Exploring Heeramandi Star's Ethnic Style Statements, Bookmark Now!
Don't Miss
- Finance 1:2 Split, 70% Dividend YTD: ICICI Direct Gives Buy On Cochin Shipyard; Miniratna Stock Up 280% In 1 Year
- Sports Rajasthan Royals Rising Star Riyan Parag's Redemption Story Takes Center Stage in IPL 2024
- Movies Krishna Mohini Promo: Fahmaan Khan- Debattama Saha's New Show Looks Promising, To REPLACE THIS Drama?
- News Jailed Gangster-Turned-Politician Mukhtar Ansari Dies Of Heart Attack
- Automobiles Xiaomi SU7 Electric Car Launched – May End Apple Inc.
- Technology HONOR Pad 9 With Bluetooth Keyboard Up For Grabs At Rs 22,499 in India
- Education RSMSSB Junior Instructor Recruitment 2024; Apply online for 2500 Posts, Check out for more details
- Travel Explore Tamil Nadu's Diverse Wedding Venues
New Anti-Migraine Drugs On The Anvil
Scientists have made a major breakthrough in migraine therapy by developing new anti-migraine drugs with fewer side effects, which according to them, will soon hit the markets.
These drugs would have an upper hand on existing therapies, said scientists, who developed these drugs, owing to improved understanding of the mechanism that makes the brain over-react to stimuli.
Peter Goadsby, leader of the headache group at the Institute of Neurology, University College London, said that this step would help them welcome a new era in management of this debilitating condition.
Migraine is a hereditary illness that affects 15 per cent of all adults, and is caused by an "oversensitive" brain, which reacts to triggers such as fatigue, hunger, stress or the weather with a throbbing, one-sided headache, often accompanied by nausea and visual disturbances. It is three times more common in women than in men.
Out of the new drugs, one is a rescue treatment known only by its code MK0974, and it works by disrupting the series of chemical reactions in the brain that cause a migraine and that too at a different point from existing drugs.
According to studies, the brain releases the chemical calcitonin gene-related peptide (CGRP) during a migraine. While the drugs that are in use these days, called triptans, block the release of the chemical, one of the new drugs, called a CGRP antagonist, obstructs the uptake of the chemical by neighbouring nerve cells.
The results of the final trial indicate that MK0974 reduces pain and is far better at preventing the return of the migraine over 24 hours in comparison to existing triptan drugs, of which the best known is sumatriptan.
"[MK0974] is very well tolerated and does really well compared with current treatments. It is going to be an important advance. We are well on the way to having a totally novel way of treating migraine," The Independent quoted Goadsby, as saying.
The results of the final trail will be presented to the American Headache Society.
- healthSeasonal Illnesses On A Rise: Are You Following The Right Prevention Methods?
- wellnessCoronavirus: How To Maintain Hand And Respiratory Hygiene
- wellness8 Common Health Problems That Occur During The Winter Season
- disorders cureSchizophrenia: Causes, Symptoms And Treatment
- disorders cureHow Effective Is Bloodletting Therapy?
- wellnessHow To Help Someone With Anosognosia?
- wellnessEverything You Need To Know About Psychosomatic Disorder
- wellnessWhat Is Hypnotherapy And How Does It Work?
- wellnessWhat Happens When We Drink Milk After Eating Chicken
- wellnessThings To Do When Someone Close To You Is Suffering From Mental Health Issues
- wellnessHow Physical Condition Affects Mental Health
- wellnessNew Smartphone App To Help Manage Mental Illness Developed